Is Pfizer Inc. (PFE) a Stock to Watch After Gaining 1.86% This Week?

The market has been high on Pfizer Inc. (PFE) stock recently. PFE gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Pfizer Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PFE!

See Full PFE Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With PFE Stock Today?

Pfizer Inc. (PFE) stock is trading at $40.60 as of 11:06 AM on Monday, Mar 20, a gain of $0.50, or 1.25% from the previous closing price of $40.10. The stock has traded between $39.94 and $40.60 so far today. Volume today is low. So far 3,571,083 shares have traded compared to average volume of 22,409,623 shares. To screen for more stocks like Pfizer Inc. click here.

More About Pfizer Inc.

Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. Click Here to get the full Stock Report for Pfizer Inc. stock.